CHOROIDAL NEOVASCULARIZATION IN A CASE OF CHORIORETINAL COLOBOMA TREATED WITH INTRAVITREAL ANTI-VEGF INJECTONS: A CASE REPORT

Keyphrases

• Intravitreal anti-VEGF 100%
• Myopic Choroidal Neovascularization (mCNV) 100%
• Chorioretinal Coloboma 100%
• Left Eye 85%
• Coloboma 71%
• Best-corrected Visual Acuity 57%
• Iris 42%
• Loading Dose 42%
• Treatment Completion 28%
• Macular 28%
• Intravitreal Anti-vascular Endothelial Growth Factor Injection 28%
• Optical Coherence Tomography 14%
• Bevacizumab 14%
• Functional Outcome 14%
• Older Women 14%
• Congenital Anomalies 14%
• Right Eye 14%
• Macular Edema 14%
• Dosing Regimen 14%
• Anatomical Outcome 14%
• Rare Complication 14%
• Blurred Vision 14%
• Subretinal Fluid 14%
• Anti-VEGF Therapy 14%
• Posterior Segment 14%
• Fissure 14%
• Choroidal Fissure 14%
• Soft Drusen 14%

Medicine and Dentistry

• Vasculotropin 100%
• Choroidal Neovascularization 100%
• Coloboma 100%
• Visual Acuity 36%
• Loading Drug Dose 27%
• Iris 27%
• Choroid 27%
• Optical Coherence Tomography 9%
• Bevacizumab 9%
• Congenital Malformation 9%
• Drug Dose Regimen 9%
• Subretinal Fluid 9%
• Blurred Vision 9%
• Macular Edema 9%
• Drusen 9%

Nursing and Health Professions

• Vasculotropin 100%
• Subretinal Neovascularization 100%
• Coloboma 100%
• Visual Acuity 36%
• Loading Drug Dose 27%
• Congenital Malformation 9%
• Bevacizumab 9%
• Drug Dose Regimen 9%
• Optical Coherence Tomography 9%
• Blurred Vision 9%
• Subretinal Fluid 9%
• Macular Edema 9%
• Drusen 9%